Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program

Schizophrenia Research

Volumn 126, Issue 1-3, 2011, Pages 277-283

  Mann Wrobel, Monica C ^a   Bennett, Melanie E ^a,b   Weiner, Elaine E ^b   Buchanan, Robert W ^b   Ball, M Patricia ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Motivation; Schizophrenia; Self efficacy; Smoking; Stages of change

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ANXIETY DISORDER; ARTICLE; ATTITUDE TO CHANGE; BOREDOM; CLINICAL ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ERUPTION; EMOTIONAL DISORDER; HUMAN; HYPONATREMIA; INSOMNIA; INTERVENTION STUDY; MOTIVATION; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOSIS; PSYCHOTHERAPY; RESTLESSNESS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEDATION; SELF CONCEPT; SIDE EFFECT; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; XEROSTOMIA;

ADULT; CARBON MONOXIDE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; SMOKING CESSATION;

EID: 79952007178     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.10.030     Document Type: Article

References (55)

1. Addington J., el-Guebaly N., Addington D., Hodgins D. Readiness to stop smoking in schizophrenia. Can. J. Psychiatry 1997, 42:49-52.
2. Addington J., el-Guebaly N., Campbell W., Hodgins D.C., Addington D. Smoking cessation treatment for patients with schizophrenia. Am. J. Psychiatry 1998, 155:974-976.
3. Baker A., Richmond R., Haile M., Lewin T.J., Carr V.J., et al. Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Res. 2007, 150:141-152.
4. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol. Rev. 1977, 84:191-215.
5. Berg C.J., Cox L.S., Mahnken J.D., Greiner K., Ellerbeck E.F. Correlates of self-efficacy among rural smokers. J. Health Psychol. 2008, 13:416-421.
6. Blanchard J.J., Mueser K.T., Bellack A.S. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr. Bull. 1998, 24:413-424.
7. Boardman T., Catley D., Mayo M.S., Ahluwalia J.S. Self-efficacy and motivation to quit during participation in a smoking cessation program. Int. J. Behav. Med. 2005, 12:266-272.
8. Bock B.C., Marcus B.H., Rossi J.S., Redding C.A. Motivational readiness for change: diet, exercise, and smoking. Am. J. Health Behav. 1998, 22:248-258.
9. Carbonari J.P., DiClemente C.C., Zweben A. A readiness to change measure. Paper presented at the national meeting of the Association for the Advancement of Behavior Therapy. San Diego, CA 1994.
10. Compton M.T., Daumit G.L., Druss B.G. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective. Harv. Rev. Psychiatry 2006, 14:212-222.
11. Cooney N.L., Litt M.D., Cooney J.L., Pilkey D.T., Steinburg H.R., Oncken C.A. Alcohol and tobacco cessation in alcohol-dependent smokers: analysis of real-time reports. Psychol. Addict. Behav. 2007, 21:277-286.
12. Copeland A.L., Brandon T.H., Quinn E.P. The Smoking Consequences Questionnaire-Adult: measurement of smoking outcome expectancies of experienced smokers. Psychol. Assess. 1995, 7:484-494.
13. Crittenden K.S., Manfredi C., Lacey L., Warnecke R., et al. Measuring readiness and motivation to quit smoking among women in public health clinics. Addict. Behav. 1994, 19:497-507.
14. de Leon J., Dadvand M., Canuso C., White A.O., et al. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am. J. Psychiatry 1995, 152:453-455.
15. DHHS USDoHaHS, National Center for Health Statistics The Third National Health and Nutrition Examination Survey 1988-94 (NHANES III) 1998, MD Center for Disease Control and Prevention, Hyattsville, MD.
16. DiClemente C.C. Self-efficacy and smoking cessation maintenance: a preliminary report. Cogn. Ther. Res. 1981, 5:175-187.
17. DiClemente C.C., Hughes S.O. Stages of change profiles in outpatient alcoholism treatment. J. Subst. Abuse 1990, 2:217-235.
18. DiClemente C.C., Carbonari J.P., Montgomery R.P., Hughes S.O. The Alcohol Abstinence Self-Efficacy scale. J. Stud. Alcohol 1994, 55:141-148.
19. DiClemente C.C., Fairhurst S.K., Piotrowski N.A. 1995. Self-efficacy and addictive behaviors. Maddux, James E:109-41.
20. DiClemente C.C., Prochaska J.O. 1998. Toward a comprehensive, transtheoretical model of change: Stages of change and addictive behaviors. Miller, William R:3-24.
21. Dixon L., Medoff D.R., Wohlheiter K., DiClemente C., Goldberg R., et al. Correlates of severity of smoking among persons with severe mental illness. Am. J. Addict. 2007, 16:101-110.
22. Esterberg M.L., Compton M.T. Smoking behavior in persons with a schizophrenia-spectrum disorder: a qualitative inves tigation of the transtheoretical model. Soc. Sci. Med. 2005, 61:293-303.
23. Etter M., Mohr S., Garin C., Etter J.-F. Stages of change in smokers with schizophrenia or schizoaffective disorder and in the general population. Schizophr. Bull. 2004, 30:459-468.
24. Evins A., Mays V.K., Rigotti N.A., Tisdale T., Cather C., Goff D.C. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob. Res. 2001, 3:397-403.
25. Evins A., Gather C., Rigotti N.A., Freudenreich O., Henderson D.C., et al. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. J. Clin. Psychiatry 2004, 65:307-311.
26. Evins A., Deckersbach T., Cather C., Freudenreich O., Culhane M.A., et al. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. J. Clin. Psychiatry 2005, 66:1184-1190.
27. Font-Mayolas S., Planes M., Gras M., Sullman M.J. Motivation for change and the pros and cons of smoking in a Spanish population. Addict. Behav. 2007, 32:175-180.
28. Forchuk C., Norman R., Malla A., Martin M.-L., McLean T., et al. Schizophrenia and the motivation for smoking. Perspect. Psychiatr. Care 2002, 38:41-49.
29. George T.P., Vessicchio J.C., Termine A., Bregartner T.A., Feingold A., et al. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol. Psychiatry 2002, 52:53-61.
30. Gwaltney C.J., Metrik J., Kahler C.W., Shiffman S. Self-efficacy and smoking cessation: a meta-analysis. Psychol. Addict. Behav. 2009, 23:56-66.
31. Hall R.G., Duhamel M., McClanahan R., Miles G., et al. Level of functioning, severity of illness, and smoking status among chronic psychiatric patients. J. Nerv. Ment. Dis. 1995, 183:468-471.
32. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.-O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 1991, 86:1119-1127.
33. Hughes J.R. Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment. J. Clin. Psychiatry 1993, 54:109-114.
34. Keefe R.S., Bilder R.M., Harvey P.D., Davis S.M., Palmer B.W., et al. Baseline neurocognitive deficits in the CATIE Schizophrenia Trial. Neuropsychopharmacology 2006, 31:2033-2046.
35. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry 1997, 4:231-244.
36. Leas L., McCabe M. Health behaviors among individuals with schizophrenia and depression. J. Health Psychol. 2007, 12:563-579.
37. Lloyd-Richardson E.E., Stanton C.A., Papandonatos G.D., Betancourt R.M., Stein M., et al. HIV-positive smokers considering quitting: differences by race/ethnicity. Am. J. Health Behav. 2008, 32:3-15.
38. McBride C.M., Curry S.J., Stephens R.S., Wells E.A., Roffman R.A., Hawkins J. Intrinsic and extrinsic motivation for change in cigarette smokers, marijuana smokers, and cocaine users. Psychol. Addict. Behav. 1994, 8:243-250.
39. McCaul K.D., Mullens A.B., Romanek K.M., Erickson S.C., Gatheridge B.J. The motivational effects of thinking and worrying about the effects of smoking cigarettes. Cogn. Emotion 2007, 21:1780-1798.
40. Newcomer J.W. Medical risk in patients with bipolar disorder and schizophrenia. J. Clin. Psychiatry 2006, 67(Suppl 9):25-30. discussion 6-42.
41. Nidecker M., DiClemente C.C., Bennett M.E., Bellack A.S. Application of the transtheoretical model of change: psychometric properties of leading measures in patients with co-occurring drug abuse and severe mental illness. Addict. Behav. 2008, 33:1021-1030.
42. Pederson L.L., Strickland C., DesLauriers A. Self-efficacy related to smoking cessation in general practice patients. Int. J. Addict. 1991, 26:467-485.
43. Peele S. What works in addiction treatment and what doesn't: is the best therapy no therapy?. Int. J. Addict. 1990, 25:1990-1991.
44. Prochaska J.O., DiClemente C.C. The Transtheoretical Approach: Crossing the Traditional Boundaries of Therapy 1984, Krieger, Malabar, FL.
45. Prochaska J.O., DiClemente C.C. Stages of change in the modification of problem behaviors. Prog. Behav. Modif. 1992, 28:183-218.
46. Prochaska J.O., DiClemente C.C., Norcross J.C. In search of how people change: applications to addictive behaviors. Am. Psychol. 1992, 47:1102-1114.
47. Scholte R.H., Breteler M.H. Withdrawal symptoms and previous attempts to quit smoking: associations with self-efficacy. Subst. Use Misuse 1997, 32:133-148.
48. Shiffman S., Balabanis M.H., Paty J.A., Engberg J., Gwaltney C.J., Liu K.S., Gnys M., Hickcox M., Paton S.M. Dynamic effects of self-efficacy on smoking lapse and relapse. Health Psychol. 2000, 19:315-323.
49. Shopland D., Hartman A.M., Bigson J.T., Mueller M.D., Kessler L.G., Lynn W.R. Cigarette smoking among U.S. adults by state and region: estimates from the current population survey. J. Natl Cancer Inst. 1996, 88:1748-1758.
50. Steinberg L. Adolescence 1998, McGraw-Hill College companies, New York, NY.
51. Tanskanen A., Viinamaki H., Koivumaa-Honkanen H.-T., Jaaskelainen J., Lehtonen J. Smoking among psychiatric patients. Eur. J. Psychiat. 1997, 11:179-188.
52. Tate S.R., Wu J., McQuaid J.R., Cummins K., Shriver C., et al. Comorbidity of substance dependence and depression: role of life stress and self-efficacy in sustaining abstinence. Psychol. Addict. Behav. 2008, 22:47-57.
53. Weiner E., Ball M., Summerfelt A., Gold J., Buchanan R.W. Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. Am. J. Psychiatry 2001, 158:635-637.
54. Ziedonis D.M., George T.P. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical Issues. Schizophr. Bull. 1997, 23:247-254.
55. Ziedonis D.M., Trudeau K. Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophr. Bull. 1997, 23:229-238.